Cargando…
New Directions in the Therapy of Glioblastoma
SIMPLE SUMMARY: Despite the continuous development of treatment technology, glioblastoma remains a challenge for modern medicine. The standard of care remains a radical surgical resection combined with adjuvant radiotherapy and chemotherapy with temozolomide. However, the usage of these procedures i...
Autores principales: | Szklener, Katarzyna, Mazurek, Marek, Wieteska, Małgorzata, Wacławska, Monika, Bilski, Mateusz, Mańdziuk, Sławomir |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9655599/ https://www.ncbi.nlm.nih.gov/pubmed/36358795 http://dx.doi.org/10.3390/cancers14215377 |
Ejemplares similares
-
Enhancing glioblastoma treatment through the integration of tumor-treating fields
por: Szklener, Katarzyna, et al.
Publicado: (2023) -
New Directions and Challenges in Targeted Therapies of Advanced Bladder Cancer: The Role of FGFR Inhibitors
por: Szklener, Katarzyna, et al.
Publicado: (2022) -
Ibrutinib in the Treatment of Solid Tumors: Current State of Knowledge and Future Directions
por: Szklener, Katarzyna, et al.
Publicado: (2022) -
Dietary Supplements in Chemotherapy-Induced Peripheral Neuropathy: A New Hope?
por: Szklener, Katarzyna, et al.
Publicado: (2022) -
Ozone in Chemotherapy-Induced Peripheral Neuropathy—Current State of Art, Possibilities, and Perspectives
por: Szklener, Katarzyna, et al.
Publicado: (2023)